Scaling up stigma? The effects of antiretroviral roll-out on stigma and HIV testing. Early evidence from rural Tanzania by Roura, M et al.
Scaling up stigma? The effects of antiretroviral roll-
out on stigma and HIV testing. Early evidence from
rural Tanzania
M Roura,
1 M Urassa,
2 J Busza,
1 D Mbata,
2 A Wringe,
1 B Zaba
1
1Centre for Population Studies,
Department of Epidemiology and
Population Health, 49–51
Bedford Square, London School
of Hygiene and Tropical
Medicine, London, UK;
2The
TAZAMA Project, The Tanzanian
National Institute of Medical
Research, Mwanza, Tanzania
Correspondence to:
Dr M Roura, The Tanzanian
National Institute of Medical
Research, PO Box 1462, Isamilo,
Mwanza, Tanzania;
maria.roura@lshtm.ac.uk
Accepted 5 November 2008
Published Online First
26 November 2008
This paper is freely available
online under the BMJ Journals
unlocked scheme, see http://
sti.bmj.com/info/unlocked.dtl
ABSTRACT
Objective: To investigate the interplay between anti-
retroviral therapy (ART) scale-up, different types of stigma
and Voluntary Counselling and Testing (VCT) uptake
2 years after the introduction of free ART in a rural ward
of Tanzania.
Methods: Qualitative study using in-depth interviews and
group activities with a purposive sample of 91 community
leaders, 77 ART clients and 16 health providers. Data
were analysed for recurrent themes using NVIVO-7
software.
Results: The complex interplay between ART, stigma and
VCT in this setting is characterised by two powerful but
opposing dynamics. The availability of effective treatment
has transformed HIV into a manageable condition which is
contributing to a reduction in self-stigma and is
stimulating VCT uptake. However, this is counterbalanced
by the persistence of blaming attitudes and emergence of
new sources of stigma associated with ART provision.
The general perception among community leaders was
that as ART users regained health, they increasingly
engaged in sexual relations and ‘‘spread the disease.’’
Fears were exacerbated because they were perceived to
be very mobile and difficult to identify physically. Some
leaders suggested giving ART recipients drugs ‘‘for
impotence,’’ marking them ‘‘with a sign’’ and putting them
‘‘in isolation camps.’’ In this context, traditional beliefs
about disease aetiology provided a less stigmatised
explanation for HIV symptoms contributing to a situation
of collective denial.
Conclusion: Where anticipated stigma prevails, provision
of antiretroviral drugs alone is unlikely to have sufficient
impact on VCT uptake. Achieving widespread public health
benefits of ART roll-out requires community-level interven-
tions to ensure local acceptability of antiretroviral drugs.
WHO’s ‘‘365 strategy’’ was preceded by a wide
debate about the feasibility and sustainability of
antiretroviral therapy (ART) in resource poor
settings, and potential synergies and conflicts
between HIV treatment and prevention. Some
argued that either treatment or prevention should
be prioritised
1 and warned about non-compliance
and a potential increase in sexual risk behaviour,
2
while others highlighted the limited efficacy of
prevention-only programmes
3 and assumed that
ART roll-out would lead to a reduction in stigma
by turning AIDS into a manageable condition. This
would subsequently lead to improved rates of HIV
testing
45and safer sexual behaviours.
In 2002 UNAIDS declared ‘‘treatment and care
for people with HIV/AIDS as fundamental to the
AIDS response and its prevention,’’
6 and by 2003,
WHO cited ART’s potential to reduce stigma and
stimulate the uptake of VCT.
7 Yet stigma con-
tinues to pose barriers to HIV testing.
8–10
Some documented examples exist to suggest
possible change. ART distribution initiatives in
Haiti and South Africa, for instance, reported
declines in stigma, increased HIV testing
11 12 and
strengthened HIV prevention.
3 While such experi-
ences demonstrate the potential of treatment
availability to dramatically reduce stigma and
increase VCT uptake, ‘‘the global coverage of
HIV testing remains unsatisfactorily low’’
13 despite
progress made towards universal access. Recent
studies in Sub-Saharan Africa (SSA) have further
documented increased sexual risk taking after initiat-
ing ART
14 and, for those testing negative, after
undergoing VCT.
15 The impact of ART provision on
stigma reduction and VCT thus does not seem to be
as clear as initially hoped. In Botswana, early
provision of ART therapy did not encourage wide-
spread testing, and HIV-related stigma persists.
16
Similar findings have been reported in other SSA
countries with generalised epidemics.
17 18
The relationship between ART and different
forms of stigma is rarely addressed in empirical
studies, despite well-conceptualised typologies of
stigma existing in the literature.
19
This qualitative study investigated the new
dynamics between HIV stigma, ART provision
and VCT uptake 2 years after the introduction of
free antiretroviral (ARV) drugs in a rural ward of
North Tanzania.
Study location
This study was conducted in Kisesa, a ward located
in North Tanzania where a monitoring project is
documenting the implementation of the national
ART programme within a cohort study established
in 1994.
VCT services are available from a clinic in the
trade centre and at temporary village-based facil-
ities during periodical surveillance rounds. Referrals
to the ART clinic located 20 km away in Mwanza
city have been facilitated from VCT services in the
ward since 2005. During the most recent surveil-
lance round, 17.3% of the adult population agreed
to undergo VCT in village-based mobile clinics, and
routine data from the permanent clinic suggest
that increases in VCT uptake during the first 2
years of the service have been slow.
Theoretical framework
Drawing from ‘‘blaming models’’ and the concep-
tual work of Deacon, we understood stigma as ‘‘an
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projecting controllable risk, and therefore blame, onto out-
groups.’’
19 This process creates boundaries between the ‘‘nor-
mal’’ and those who are ‘‘discredited within a local moralistic
system’’
20 and may be used as an instrument to maintain the
‘‘social order.’’
19 21 HIV stigma would then be based on both
‘‘disease avoidance’’ and ‘‘norm enforcement.’’
22
METHODS
Semistructured interviews and group activities based on visual
outputs were conducted with 91 community leaders, 77 ART
clients and 16 health providers (table 1). Theoretical sampling
was used, where participants continue to be recruited until no
new information emerges.
With the aid of six resident fieldworkers involved in the
cohort study, all the village-level leaders of the ward were
invited to participate, and a sample of subvillage and ten-cell
leaders was purposefully selected to ensure balanced geographi-
cal representation.
Influential individuals often consulted for advice (‘‘Maarufu’’)
and other informal leaders were identified through snowball
techniques whereby sampled individuals suggested additional
participants through mapping exercises. Building consensus
within the group during the identification of influential persons
was a core component of the activity in order to prevent
informants from directing us towards closely related villagers
likely to hold similar opinions.
Persons living with HIV/AIDS (PLHA) were purposively
sampled to ensure the distribution across sex, age and area of
residence reflected that of all referrals made by the VCT centre.
Invitations were delivered through the VCT counsellors and
during monthly post-test club meetings. Both individual inter-
views and group discussions were conducted in order to identify
any potential reporting bias.
The fieldwork guidelines consisted of open-ended questions
without explicit references to stigma. The iterative approach
adopted—in which data collection and analysis take place
simultaneously—allowed for ongoing refining of field tools as
relevant topics emerged.
Informed consent wasobtainedfrom allparticipants, and verbal
data were tape-recorded, transcribed and translated into English.
Fieldworkernotesprovidednon-verbalinformation andpicturesof
visual outputs facilitated analysis and cross-case comparison.
The software package NVIVO 7 was used to identify major
themes. The first author analysed 15 sample transcripts to
develop a coding frame centred on the main types and sources of
stigma (table 2). This was amended throughout coding (box 1).
A second researcher independently coded a random selection of
data in the original language. Emerging hypotheses were
Table 1 Characteristics of the study sample (n=184)
Trade centre Rural areas Total
Community leaders 33 58 91
Formally elected
Village leaders 4 6 10
Ten-cell and subvillage leaders 18 40 58
Informal
Faith leaders 3 4 7
Village advisers (‘‘maarufu’’) 6 6 12
Traditional healers 2 2 4
Persons living with HIV/AIDS 39 38 77
Male 20 18 38
Female 19 20 39
Health providers 9 7 16
Facility-based 7 4 11
Community-based 2 3 5
Total 184
Table 2 Different types and sources of HIV stigma
Types of stigma
Discrimination Enacted stigma; what people do to unfairly disadvantage known or suspected HIV positive
persons, such as exclusion from shared activities
Anticipated stigma The stigma people expect from others if they were known to be HIV positive
Self-stigma Internalised feelings of shame or blame derived from accepting stigmatising judgements of
one’s identity
Secondary stigma Stigma which, by association, affects those related to the infected
Sources of stigma
Burden Stigma derived from the inability of individuals to conduct productive activities and look after
themselves, leading them to be perceived as a ‘‘drain of resources’’
Fear Stigma derived from the fear of being infected by HIV through casual or sexual contact
Blame Stigma derived from the association of HIV with negatively defined behaviours or groups in
society, which are subsequently blamed for their infection
Source: Based on Deacon H (2005) Understanding HIV/AIDS stigma. A theoretical and methodological analysis. Research
Monograph. London: HSRC Press, 2005.
Box 1 Coding framework
1. Types of stigma
c Discrimination
c Anticipated stigma
c Self-stigma
c Secondary stigma
c Multiple stigma
2. Sources of stigma
c Burden
c Fear
c Blame
c New sources
– ‘‘They spread the disease’’
– Hungry/greedy
3. Attitudes
c Normalisation
c Diversity
c Contradictions
c By population groups (sex, age and income)
c Collective denial
– ‘‘Kondela’’
– Blaming others (‘‘Othering’’)
Health services research
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interpretations.
Ethical approval was obtained from the LSHTM Ethics
Committee and the Tanzanian Medical Research
Coordinating Committee.
RESULTS
TowardsanormalisationofHIV:‘‘Ithasbecomethesameasfever’’
Burden-related stigma, focused around the inability of PLHA to
conduct routine activities, emerged as a major source of HIV
stigma in this community. As ART visibly restored normalcy in
clients’ productive lives, this source of stigma appeared to
decrease, as did PLHA’s own feelings of shame. Many felt
comforted that the disease had become ‘‘just like malaria’’ and
mentioned feeling ‘‘like a normal person.’’ They reported
realising that the disease was ‘‘for everyone,’’ including
‘‘innocent’’ and ‘‘respectable’’ people, through interaction with
health professionals and other PLHA at the ART clinic.
I just felt good because this disease has now become just as any
other disease…she told me that I should be calm: ‘‘you just get
treatment, this has become just like fever’’… (ART user, trade
centre, female)
This catastrophe is not for me alone…it can affect anyone. (ART
user, remote rural, male)
ART clients were successfully encouraging others to seek
treatment, and a few reported that they had been tested after
being advised by a person already on antiretrovirals (ARVs).
… they are going in front telling: ‘‘I am HIV positive…I am OK,
so come and check your health so you can start ART early before
becoming sick’’… (healthcare provider, female)
Pervasive blame: ‘‘All of this because of a two minutes pleasure’’
Most community leaders interviewed attributed HIV infection
to personal decisions over sex life and alcohol consumption.
Such behaviours were perceived as degrading and avoidable, and
PLHA were consequently accused of being ‘‘negligent,’’ ‘‘irre-
sponsible’’ and ‘‘lazy.’’ Greater blame was placed on those who
consumed alcohol, and if they experienced treatment failure,
this was assumed to be due to sexual activity while on ARVs,
and thus a ‘‘deserved’’ outcome of unacceptable behaviour.
…they die because of negligence. Even after you die they will say:
‘‘this old man has caused problems to his children. If he was alive
his children wouldn’t be in this situation, but all this is because of
a two minutes pleasure’’… (VL9, semi rural, male)
Others have used them (ARVs) wrongly. God was pleased to take
them early…but all of them were using the drugs and still having
sex with other women. (VL3, trade centre, male)
This disease is transmitted through immorality. (TH1, remote
rural, female)
Women were sometimes accused of ‘‘provoking men’’ but
could be exempted from blame due to poverty and power-
lessness.
Respondents credited HIV education with decreasing local
stigma. However, the impact seemed superficial, considering the
wide heterogeneity of attitudes towards PLHA, the frequency of
contradictory statements and the persistence of anticipated
stigma as a leading barrier to VCT uptake.
Some are sad and others are happy when someone is sick because
maybe s/he was very promiscuous. Now s/he has been caught.
(VL2, semi rural, male)
Youth find it difficult: ‘‘If they see me there (VCT centre) I will
lose girlfriends, I will lose money’’… (VA1, trade centre, male)
Scaling up stigma? ‘‘Let him take these medicines, but he should
be made impotent’’
The majority of community leaders interviewed expressed deep
worries about a potential increase in HIV incidence as a direct
consequence of ART roll-out. This concern was also raised
Figure 1 Effect of antiretroviral (ARV) provision on HIV stigma and Voluntary Counselling and Testing (VCT) uptake: early evidence from rural
Tanzania. ART, antiretroviral therapy; PLHA, persons living with HIV/AIDS.
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five villages where group discussions took place. The general
perception among both formal and informal leaders and across
groups of sex and area of residence was that as PLHA regained
weight and health, they were increasingly engaging in sexual
relations and ‘‘spreading the disease.’’ In exceptional cases,
participants believed that PLHA had reduced the frequency of
sex because they were being ‘‘avoided by others.’’ However, in
general terms, fears surrounded the belief that PLHA on ART
looked ‘‘attractive’’ and could not be physically identified.
Furthermore, they were perceived to ‘‘live longer’’ and ‘‘move
around,’’ giving additional opportunity to spread the disease.
Other concerns were that HIV drugs caused mental disorders,
‘‘aggressiveness,’’ ‘‘gluttony’’ and ‘‘greed.’’ In a context of
extreme poverty, the economic and nutritional aid provided to
ART clients through support programmes was not always
appreciated by other community members. Some village leaders
suggested public disclosure of HIV test results, giving ART
recipients drugs ‘‘to make them impotent,’’ marking them with
a sign and putting them ‘‘in isolation camps’’ (box 2).
Collective denial: ‘‘AIDS doesn’t exist. We just bewitch each
other’’
The belief that a wide array of diseases can be caused by witches
as a consequence of jealousy or revenge is widespread in this
community. Some community leaders referred to a disease from
the past (‘‘Kondela’’), which looked like AIDS, was caused by
witches and could be cured by Traditional Healers specialised in
‘‘divination.’’
In the past the Sukuma called it ‘‘Kondela.’’ A person slims and
looks like s/he is HIV positive, but s/he is not. It’s a disease
similar to AIDS caused by medicines of the witches. It is often
used if you quarrel with someone… if s/he has got that medicine
s/he bewitches you. (VA1, trade centre, male)
Contrary to PLHA, people suffering from ‘‘Kondela’’ were not
feared or blamed for a condition which was perceived to have
been caused ‘‘to’’ them and not ‘‘by’’ them. This contributed to
a situation of collective denial with a negative effect on VCT
uptake.
Their relationship with him/her is good because they believe that
s/he is bewitched… because they don’t really believe that this
person has AIDS. If they really knew that this person has AIDS
it’s tough in the village. S/he is not taken care of. They say: ‘‘s/he
wanted it, s/he liked it.’’ They know that s/he got it through sex.
(VA7, semi rural, female)
They had false beliefs that perhaps s/he is bewitched…s/he says:
‘‘I have no disease, they are lying, they didn’t check it well…’’
(healthcare provider 4, female)
if s/he dies…one group will say it’s AIDS… but his/her close
relatives will oppose it: ‘‘it wasn’t AIDS, it was ‘‘this and this’’
(witchcraft) …s/he has passed away on unidentified disease-
s…and s/he wasn’t even checked. (VL5, trade centre, male)
DISCUSSION
Our findings cast doubts on the assumption that ARV provision
will lead to a reduction in stigma and a substantial increase in
VCT uptake. Instead, two seemingly opposing dynamics
emerge. On the one hand, the availability of effective treatment
has transformed HIV into a chronic, invisible and manageable
condition which is contributing to a reduction in self-stigma
and growing openness among ART clients. Such ‘‘normal-
isation’’ of the disease can encourage VCT uptake. On the other
hand, the persistence of blaming attitudes in the community
and the emergence of new sources of stigma directly associated
with ARV provision fuel stubbornly high levels of anticipated
stigma, which contribute to disease denial and discourage VCT
uptake (fig 1). These counterbalancing trends are likely to explain
the relatively slow increase in the rate of VCT uptake, and
context-specific manifestation of each type of stigma will need to
be considered in order to develop appropriate interventions.
Where PLHA are blamed for their condition, identified as a
modern, sexually transmitted disease, and belief in supernatural
forces as the origin of a wide array of diseases prevails, there
might be further incentives to avoid testing and the risk of
receiving a clear HIV diagnosis. As some cases of witchcraft are
not subject to social sanction, cultural beliefs about disease
aetiology provide a mechanism to blame others and turn the
Box 2 Scaling up stigma?
c These antiretrovirals are not useful…they make him look
healthy so if you don’t know him you may have sex with him
and then you are infected too. We advise the government and
relevant organisations that once someone is discovered to be
HIV positive he should be given medicine to make him
impotent. Let him take these medicines and become fat but he
should be made impotent so that he should not look for
women anymore. (VL1, semirural, male)
c …when s/he will see that his health is good s/he will continue
spreading infections…The government should mark them so
we can know who is infected…a certain region for those
people with HIV would be safe. (VL10, remote rural, male)
c …people are getting drugs and their conditions become
well…someone can go to have sex with them, they think that
this person is well…others are even getting married…I think
the disease will spread because of those drugs. (VA2, trade
centre, female)
c ….they are continuing bearing children. If the community has
three families of that type many children will be sick. (Group
activity 2, remote rural, males and females)
c they start saying that these people are spreading AIDS. They
are just going to get AIDS drugs. Now we live just like that…
without testing… (VA4, remote rural, female)
Key messages
c There is insufficient evidence for the common assumption that
antiretroviral therapy (ART) provision automatically leads to
reduction in stigma and increased HIV test uptake.
c In our study setting, the complex interplay between ART, HIV
stigma and Voluntary Counselling and Testing (VCT) is
characterised by two powerful dynamics in different
directions.
c The positive impact of HIV normalisation on VCT uptake is
counterbalanced by persistent blaming attitudes and the
emergence of new sources of stigma.
c Achieving widespread public health benefits of ART roll-out
requires community-level interventions to ensure local
acceptability of antiretroviral drugs.
Health services research
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confronting the epidemic.
Targeted interventions may be required to prevent a scale-up
of new types of stigma, tackle the deeply rooted association of
HIV with ‘‘immoral behaviour,’’ and ensure the local accept-
ability of ART. Community leaders, opinion makers and
representatives of community-based organisations should be
made aware of the adverse effects of stigma, and home-based
care providers should continue to act as ‘‘role models.’’ Positive
prevention messages addressed to ART clients covering all
available options should be delivered at health facilities and
community settings, and the effects of prioritising PLHA when
delivering food support within impoverished communities
considered. Opinion leaders able to influence norms and values
should closely collaborate with PLHA in community sensitisa-
tion activities promoting VCT uptake and emphasising that
HIV can affect anyone.
The proposed interventions are backed by previous initiatives
demonstrating that education interventions addressed to ART
clients can contribute to safer sexual behaviours
23 and that
existing community assets can be mobilised to tackle stigma
and promote HV testing.
24–27 However, uncertainties remain
about the overall impact of ART provision and VCT on sexual
behaviour
15 28 29 as well as the long-term effect of ART provision
on stigma and VCT uptake.
Our findings are constrained by some methodological
limitations including reliance on self-reported data and use of
snowball sampling. PLHA might have under-reported negative
experiences, and community leaders could have directed us to
persons holding similar opinions. However, the sampling of key
informants was conducted through group exercises, and we
triangulated information by using different data-collection tools
and categories of participants.
The challenges we have identified have been documented in
other areas of Tanzania
30 and are likely to be similar to those
faced in rural SSA settings where ART provision is being scaled
up through National AIDS Control Programmes.
CONCLUSION
The tendency towards a normalisation of HIV resulting from
the availability of ART provides a unique opportunity to
maximise the synergies between HIV treatment and prevention.
However, this opportunity might be lost in the absence of
vigorous community mobilisation interventions to ensure local
acceptability of ARV drugs.
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